References
De Santis CE, Ma J, Gaudet MM, et al. Breast cancer statistics, 2019. CA Cancer J Clin. 2019;69(6):438–51. https://doi.org/10.3322/caac.21583.
Warner ET, Tamimi RM, Hughes ME, et al. Racial and ethnic differences in breast cancer survival: mediating effect of tumor characteristics and sociodemographic and treatment factors. J Clin Oncol. 2015;33(20):2254–61. https://doi.org/10.1200/jco.2014.57.1349.
Tao L, Gomez SL, Keegan THM, Kurian AW, Clarke CA. Breast cancer mortality in african-american and non-hispanic white women by molecular subtype and stage at diagnosis: a population-based study. Cancer Epidemiol Biomark Prev. 2015;24(7):1039–45. https://doi.org/10.1158/1055-9965.Epi-15-0243.
Cho B, Han Y, Lian M, et al. Evaluation of racial/ethnic differences in treatment and mortality among women with triple-negative breast cancer. JAMA Oncol. 2021;7(7):1016–23. https://doi.org/10.1001/jamaoncol.2021.1254.
Adams-Campbell LL, Ahaghotu C, Gaskins M, et al. Enrollment of African Americans onto clinical treatment trials: study design barriers. J Clin Oncol. 2004;22(4):730–4. https://doi.org/10.1200/jco.2004.03.160.
Fayanju OM, Ren Y, Thomas SM, et al. A case-control study examining disparities in clinical trial participation among breast surgical oncology patients. JNCI Cancer Spectr. 2020;4(2):103. https://doi.org/10.1093/jncics/pkz103.
Mead EL, Doorenbos AZ, Javid SH, et al. Shared decision-making for cancer care among racial and ethnic minorities: a systematic review. Am J Public Health. 2013;103(12):e15–29. https://doi.org/10.2105/AJPH.2013.301631.
Guerra CE, Sallee V, Hwang W-T, et al. Accrual of black participants to cancer clinical trials following a five-year prospective initiative of community outreach and engagement. J Clin Oncol. 2021;39(15 Suppl):100. https://doi.org/10.1200/JCO.2021.39.15_suppl.100.
Donevant S, Heiney SP, Wineglass C, Schooley B, Singh A, Sheng J. Perceptions of endocrine therapy in african-american breast cancer survivors: mixed methods study. JMIR Form Res. 2021;5(6):e23884. https://doi.org/10.2196/23884.
Funding
The author is supported by the National Institutes of Health (NIH) under award number 1K08CA241390 (Principal Investigator: Fayanju). The content of this manuscript is solely the responsibility of the author and does not necessarily represent the official views of the NIH.
The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
Oluwadamilola M. Fayanju has no relevant conflicts of interest to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Fayanju, O.M. Black–White Differences in Treatment Receipt and Outcome for Triple-Negative Breast Cancer: The Competing Contributions of Access, Bias, and Biology. Ann Surg Oncol 28, 6909–6910 (2021). https://doi.org/10.1245/s10434-021-10697-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-021-10697-5